Research Article

Association of Soluble Klotho Level with Adverse Outcomes in Patients on Maintenance Hemodialysis

Table 1

Comparison of demographic and clinical data in enrolled patients on MHD.

VariablesTotal
()

ng/ml ()

ng/ml ()
value

Ages0.283
Male (%)116 (55.0)55 (52.4)61 (57.5)0.451
Diabetes (%)16249 (23.3)23 (21.9)26 (24.5)0.652
Hypertension (%)179 (84.8)88 (83.1)91 (85.5)0.680
ACEI/ARB (%)168 (79.6)82 (78.1)86 (81.1)0.584
Vitamin D (%)176 (83.6)81 (77.1)95 (89.6)0.015
Dialysis vintage (year)0.005
Scr (μmol/L)0.016
Bun (mmol/L)0.837
KT/V (per week)0.682
HGB (g/L)0.337
Ca (mmol/L)0.136
P (mmol/L)0.942
(mg2/dL2)0.667
ALB (g/L)0.337
iPTH (pg/mL)285.2 (137.2, 568.4)273.4 (126.4, 572.3)316.5 (163.0, 561.3)0.530
Klotho (ng/mL)1.34 (0.66, 1.95)0.66 (0.39, 0.93)1.95 (1.61, 2.26)<0.001
FGF23 (pg/mL)515.3 (401.0, 661.4)582.6 (450.6, 698.3)482.8 (352.5, 598.6)0.007

Abbreviations: MHD: maintenance hemodialysis; Scr: serum creatinine; Ca: calcium; P: phosphorus; Bun: blood urea nitrogen; ALB: albumin; HGB: hemoglobin; ACEI: angiotensin-converting enzyme inhibitors; ARB: angiotensin receptor blockers; iPTH: intact parathyroid hormone; FGF23: fibroblast growth factor 23. Data are presented as for normally distributed variables, otherwise median with 25th-75th percentile.